Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases

Proton pump inhibitors (PPIs) have been associated with decreased gut microbiota diversity. Disrupted gut microbiota composition has been reported in several autoimmune diseases (ADs), such as type 1 diabetes mellitus (DM), autoimmune thyroiditis (AIT), juvenile idiopathic arthritis (JIA), and infla...

Full description

Bibliographic Details
Main Authors: Laura Räisänen, Heli Viljakainen, Kaija-Leena Kolho
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Pediatrics
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2023.1157547/full
_version_ 1797859716017160192
author Laura Räisänen
Heli Viljakainen
Heli Viljakainen
Kaija-Leena Kolho
Kaija-Leena Kolho
author_facet Laura Räisänen
Heli Viljakainen
Heli Viljakainen
Kaija-Leena Kolho
Kaija-Leena Kolho
author_sort Laura Räisänen
collection DOAJ
description Proton pump inhibitors (PPIs) have been associated with decreased gut microbiota diversity. Disrupted gut microbiota composition has been reported in several autoimmune diseases (ADs), such as type 1 diabetes mellitus (DM), autoimmune thyroiditis (AIT), juvenile idiopathic arthritis (JIA), and inflammatory bowel diseases (IBD). We investigated whether PPIs are associated with the development of ADs in children and concluded that PPI exposures could be related to the onset of ADs, especially IBD and potentially AIT as well.
first_indexed 2024-04-09T21:34:06Z
format Article
id doaj.art-ca0002da34d4411a812625e1b62b2f8f
institution Directory Open Access Journal
issn 2296-2360
language English
last_indexed 2024-04-09T21:34:06Z
publishDate 2023-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pediatrics
spelling doaj.art-ca0002da34d4411a812625e1b62b2f8f2023-03-27T05:55:26ZengFrontiers Media S.A.Frontiers in Pediatrics2296-23602023-03-011110.3389/fped.2023.11575471157547Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseasesLaura Räisänen0Heli Viljakainen1Heli Viljakainen2Kaija-Leena Kolho3Kaija-Leena Kolho4Department of Pediatrics, Tampere University Hospital, Tampere, FinlandPublic Health Research Program, Folkhälsan Research Center, Helsinki, FinlandChildren’s Hospital, University of Helsinki and HUS, Helsinki, FinlandChildren’s Hospital, University of Helsinki and HUS, Helsinki, FinlandFaculty of Medicine and Medical Technology, Tampere University, Tampere, FinlandProton pump inhibitors (PPIs) have been associated with decreased gut microbiota diversity. Disrupted gut microbiota composition has been reported in several autoimmune diseases (ADs), such as type 1 diabetes mellitus (DM), autoimmune thyroiditis (AIT), juvenile idiopathic arthritis (JIA), and inflammatory bowel diseases (IBD). We investigated whether PPIs are associated with the development of ADs in children and concluded that PPI exposures could be related to the onset of ADs, especially IBD and potentially AIT as well.https://www.frontiersin.org/articles/10.3389/fped.2023.1157547/fullautoimmune thyroiditisinflammatory bowel diseasesjuvenile idiopathic arthritisomeprazoletype 1 diabetes mellitus
spellingShingle Laura Räisänen
Heli Viljakainen
Heli Viljakainen
Kaija-Leena Kolho
Kaija-Leena Kolho
Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases
Frontiers in Pediatrics
autoimmune thyroiditis
inflammatory bowel diseases
juvenile idiopathic arthritis
omeprazole
type 1 diabetes mellitus
title Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases
title_full Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases
title_fullStr Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases
title_full_unstemmed Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases
title_short Exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases
title_sort exposure to proton pump inhibitors is associated with the development of pediatric autoimmune diseases
topic autoimmune thyroiditis
inflammatory bowel diseases
juvenile idiopathic arthritis
omeprazole
type 1 diabetes mellitus
url https://www.frontiersin.org/articles/10.3389/fped.2023.1157547/full
work_keys_str_mv AT lauraraisanen exposuretoprotonpumpinhibitorsisassociatedwiththedevelopmentofpediatricautoimmunediseases
AT heliviljakainen exposuretoprotonpumpinhibitorsisassociatedwiththedevelopmentofpediatricautoimmunediseases
AT heliviljakainen exposuretoprotonpumpinhibitorsisassociatedwiththedevelopmentofpediatricautoimmunediseases
AT kaijaleenakolho exposuretoprotonpumpinhibitorsisassociatedwiththedevelopmentofpediatricautoimmunediseases
AT kaijaleenakolho exposuretoprotonpumpinhibitorsisassociatedwiththedevelopmentofpediatricautoimmunediseases